Skip to main content
Log in

Montelukast and Maintenance of Steroid-Induced Remission in Eosinophilic Esophagitis

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Lucendo AJ, De Rezende LC, Jiménez-Contreras S, et al. Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-011-1775-y.

  2. Daikh BE, Ryan CK, Schwartz RH. Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture. Ann Allergy Asthma Immunol. 2003;90:23–27.

    Article  PubMed  CAS  Google Scholar 

  3. Quack I, Sellin L, Buchner NJ, et al. Eosinophilic gastroenteritis in a young girl–long term remission under Montelukast. BMC Gastroenterol. 2005;5:24.

    Article  PubMed  Google Scholar 

  4. Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:1305–1313.

    Article  PubMed  Google Scholar 

  5. Aceves SS, Newbury RO, Dohil R, et al. Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder. J Clin Gastroenterol. 2007;41:252–256.

    Article  PubMed  Google Scholar 

  6. Lucendo Villarin AJ, Carrion AG, Navarro SM, et al. Eosinophilic esophagitis in adults, an emerging cause of dysphagia. Description of 9 cases. Rev Esp Enferm Dig. 2005;97:229–239.

    PubMed  CAS  Google Scholar 

  7. Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139:1526–1537.

    Article  PubMed  CAS  Google Scholar 

  8. Schäper C, Noga O, Koch B, et al. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis. J Investig Allergy Clin Immunol. 2011;21:51–58.

    Google Scholar 

  9. Attwood SE, Lewis CJ, Bronder CS, et al. Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut. 2003;52:181–185.

    Article  PubMed  CAS  Google Scholar 

  10. Stumphy J, Al-Zubeidi D, Guerin L, et al. Observations on use of montelukast in pediatric eosinophilic esophagitis: insights for the future. Dis Esophagus. 2011;24:229–234.

    Article  PubMed  CAS  Google Scholar 

  11. Sinharay R. Eosinophilic oesophagitis: treatment using Montelukast. Gut. 2003;52:1228–1229.

    Article  PubMed  CAS  Google Scholar 

  12. Gupta SK, Peters-Golden M, Fitzgerald JF, et al. Cysteinyl leukotriene levels in esophageal mucosal biopsies of children with eosinophilic inflammation: are they all the same? Am J Gastroenterol. 2006;101:1125–1128.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

We, as the sole authors of this manuscript, confirm that there is nothing to be declared concerning grant or financial support or conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Levent Filik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Filik, L. Montelukast and Maintenance of Steroid-Induced Remission in Eosinophilic Esophagitis. Dig Dis Sci 57, 258–259 (2012). https://doi.org/10.1007/s10620-011-1923-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-011-1923-4

Keywords

Navigation